Drug Type Hematopoietic stem cell therapy |
Synonyms Allogeneic human umbilical cord blood haematopoietic progenitor cell therapy(StemCyte), RegeneCyte |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | NDA/BLA | US | 22 Mar 2022 |